AcouSort AB
The answer first
Does AcouSort beat the market?
No, AcouSort has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 12% of Nordic stocks
- Quality43
- Value4
- Trend41
No. 156 of 195 in healthcare
Max for seven days
Follow AcouSort with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about AcouSort
Your first answer is free, no account needed.
Do you own AcouSort, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with AcouSort and a few more. Free, no card.
Super Stock+44.6%In short
- AcouSort has risen 3.0% over the past year, including dividends.
- Overall, AcouSort ranks better than 12% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 92.3%. The price is 91.4% below its peak now.
What do analysts think of AcouSort?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 12% of Nordic stocks.
No. 156 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 142 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity–
- Asset turnoverSales divided by everything the company owns0.37
- Return on equityProfit divided by equity−114.5%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 171 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity5.6
- P/SPrice divided by sales6.9
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Medium The share price has moved about like most stocks over the last year.
No. 82 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−10.8%
- 6 months−40.7%
- 9 months−2.5%
- 12 months+3.0%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own AcouSort
One fund we follow owns AcouSort. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About AcouSort
AcouSort AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 11 employees.
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle s…


See the full analysis of AcouSort.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card